Our data are strengthened by the observation that the influence of PCSK9 LOF genotype on markers of endothelial dysfunction was more evident after excluding patients homozygous for an LDLR variant that renders it insensitive to PCSK9. This evidence concerns the gene LDLR and endothelial dysfunction.